APOE and Alzheimer disease: Aβ oligomers, in particular, were found to be associated with cognitive deficits [3], accelerated memory impairments and early cognitive decline in ApoE ε4 carriers [27] and were identified as primary drivers for neurotoxic processes in AD [28].